Adenosine receptor agonist

This page covers all Adenosine receptor agonist drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting A2A adenosine receptor, Proto-oncogene tyrosine-protein kinase Src, A1 adenosine receptor.

Targets

A2A adenosine receptor · Proto-oncogene tyrosine-protein kinase Src · A1 adenosine receptor · A2A receptor

Marketed (2)

• Regadenoson · Pfizer Inc. · Cardiovascular
  Regadenoson is a low affinity A2A adenosine receptor agonist that produces coronary vasodilation and increases coronary blood flow.
• Adenovite · Respiratory

Phase 3 pipeline (3)

• trabodenoson 4.5% BID · Inotek Pharmaceuticals Corporation · Ophthalmology
  Trabodenoson is a selective adenosine receptor agonist that increases the activity of the A1 receptor.
• Regadenoson central - peripheral · Lokien van Nunen · Cardiovascular
  Regadenoson central - peripheral acts as an adenosine A2A receptor agonist.
• Regadenoson; Optison · University of Nebraska · Cardiovascular
  Regadenoson is a selective adenosine A2A receptor agonist.